In the studies of Vergallo et al. [26], human neuroblastomas were treated with a 0.2 T SMF and after two hours of treatment, the cell viability decreased 30% due to the overexpression of the caspase-3 protein. This evidence concerns the gene CASP3 and neuroblastoma.